Market Access Routes for Orphan Oncology Drugs- How do Health Systems Help Patients Receive Treatments that are not Cost-Effective?
Abstract
Authors
H Chevrou-Severac E Adkins DA Solaman M Ratcliffe
H Chevrou-Severac E Adkins DA Solaman M Ratcliffe
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now